LMO

Table. 4.

Status of delta percent change and delta difference application

AFP CA125 CA19-9 CEA PSA T3 Free T4 TSH
Delta percent change (%)
4.5 1 (4.8)
5 1 (4.2) 2 (8.3) 1 (4.8)
6 1 (4.2)
6.5 1 (4.5)
7 1 (4.2) 1 (4.5)
8 1 (4.0)
10 1 (4.2) 1 (4.0) 1 (4.2) 1 (4.2) 1 (4.2) 1 (4.5) 1 (4.5) 1 (4.8)
20 5 (20.8) 6 (24.0) 6 (25.0) 6 (25.0) 3 (12.5) 4 (18.2) 4 (18.2) 4 (19.0)
25 1 (4.2) 1 (4.0) 1 (4.2) 1 (4.2) 1 (4.2) 1 (4.5) 1 (4.5) 1 (4.8)
28.2 1 (4.2)
28.63 1 (4.5)
30 3 (12.5) 4 (16.0) 2 (8.3) 2 (8.3) 3 (12.5) 2 (9.1) 2 (9.1) 2 (9.5)
31.86 1 (4.5)
47.4 1 (4.2)
49.20 1 (4.2)
50 10 (41.7) 11 (44.0) 12 (50.0) 11 (45.8) 13 (54.2) 12 (54.5) 12 (54.5) 10 (47.6)
56.95 1 (4.0)
58.55 1 (4.8)
90 1 (4.2) 1 (4.2)
+200/−50 1 (4.2)
Total laboratories 24 25 24 24 24 22 22 22
Delta difference (absolute value)
0.7 1 (25.0)
1.2 1 (20.0)
1.72 1 (33.3)
2 2 (40.0) 1 (20.0)
2.6 1 (20.0)
3 1 (33.3) 1 (20.0) 2 (66.7)
4 1 (20.0)
5 2 (40.0)
8 1 (50.0)
16 1 (33.3)
20 1 (50.0)
28 1 (100.0)
30 1 (25.0)
32 1 (100.0)
50 1 (33.3)
+30/−15 2 (50.0)
+100/−50 1 (20.0)
Total laboratories 2 1 1 3 5 4 3* 5

*One laboratory did not respond to delta check criteria.

Abbreviations: AFP, alpha-fetoprotein; CA125, cancer antigen 125; CA19-9, cancer antigen 19-9; CEA, carcinoembryonic antigen; PSA, prostate-specific antigen; TSH, thyroid-stimulating hormone; T3, triiodothyronine; T4, thyroxine.

Lab Med Online 2023;13:324~331 https://doi.org/10.47429/lmo.2023.13.4.324
© Lab Med Online